Cargando…
Characterization of an active ingredient made of nanoscale iron(oxyhydr)oxide for the treatment of hyperphosphatemia
Kidney disease is one of the main non-communicable diseases. Every year millions of people worldwide die from kidney dysfunction. One cause is disturbances in the mineral metabolism, such as abnormally high phosphate concentrations in the blood, medically referred to as hyperphosphatemia. A new acti...
Autores principales: | Bäumler, Magdalena, Schwaminger, Sebastian P., von der Haar-Leistl, Daniela, Schaper, Simon J., Müller-Buschbaum, Peter, Wagner, Friedrich E., Berensmeier, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033185/ https://www.ncbi.nlm.nih.gov/pubmed/35480163 http://dx.doi.org/10.1039/d1ra00050k |
Ejemplares similares
-
Nanoscale iron (oxyhydr)oxide-modified carbon nanotube filter for rapid and effective Sb(iii) removal
por: Liu, Yanbiao, et al.
Publicado: (2019) -
Bare Iron Oxide Nanoparticles as Drug Delivery Carrier for the Short Cationic Peptide Lasioglossin
por: Turrina, Chiara, et al.
Publicado: (2021) -
Impact of Fe(III) (Oxyhydr)oxides Mineralogy on Iron Solubilization and Associated Microbial Communities
por: Zhang, Fengfeng, et al.
Publicado: (2020) -
Iron (oxyhydr)oxides are responsible for the stabilization of Cu and Zn in AMD after treatment with limestone
por: Ding, Yuan, et al.
Publicado: (2023) -
Fe(III) (oxyhydr)oxide reduction by the thermophilic iron-reducing bacterium Desulfovulcanus ferrireducens
por: Sklute, Elizabeth C., et al.
Publicado: (2023)